The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Stefano Ferrari

Istituto Ortopedico Rizzoli

Via Pupilli 1

40136 Bologna



Name/email consistency: high



  • Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136 Bologna, Italy;. 1999 - 2012
  • Sezione di Chemioterapia, dei Tumori dell' Apparato Locomotore, Istituto Ortopedico Rizzoli, via Pupilli 1, Italy. 2009 - 2010


  1. Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1. Ferrari, S., Ruggieri, P., Cefalo, G., Tamburini, A., Capanna, R., Fagioli, F., Comandone, A., Bertulli, R., Bisogno, G., Palmerini, E., Alberghini, M., Parafioriti, A., Linari, A., Picci, P., Bacci, G. J. Clin. Oncol. (2012) [Pubmed]
  2. Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study. Ferrari, S., Palmerini, E., Alberghini, M., Staals, E., Mercuri, M., Barbieri, E., Longhi, A., Cantero, L., Cesari, M., Abate, M., Balladelli, A., Picci, P., Bacci, G. Tumori (2010) [Pubmed]
  3. The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the italian rizzoli experience. Impact on the future. Ferrari, S., Palmerini, E., Staals, E.L., Mercuri, M., Franco, B., Picci, P., Bacci, G. Cancer Treat. Res. (2010) [Pubmed]
  4. Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma. Ferrari, S., Palmerini, E., Staals, E., Abate, M.E., Longhi, A., Cesari, M., Balladelli, A., Pratelli, L., Bacci, G. J. Chemother (2009) [Pubmed]
  5. Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma. Ferrari, S., del Prever, A.B., Palmerini, E., Staals, E., Berta, M., Balladelli, A., Picci, P., Fagioli, F., Bacci, G., Vanel, D. Pediatr. Blood. Cancer (2009) [Pubmed]
  6. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Ferrari, S., Zanella, L., Alberghini, M., Palmerini, E., Staals, E., Bacchini, P. Pediatr. Blood. Cancer (2008) [Pubmed]
  7. Predictive factors of histologic response to primary chemotherapy in patients with Ewing sarcoma. Ferrari, S., Bertoni, F., Palmerini, E., Errani, C., Bacchini, P., Pignotti, E., Mercuri, M., Longhi, A., Cesari, M., Picci, P. J. Pediatr. Hematol. Oncol. (2007) [Pubmed]
  8. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Ferrari, S., Palmerini, E. Curr. Opin. Oncol (2007) [Pubmed]
  9. Late relapse in osteosarcoma. Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Cesari, M., Longhi, A., Bacci, G. J. Pediatr. Hematol. Oncol. (2006) [Pubmed]
  10. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T.A., Picci, P., Capanna, R., Bernini, G., Müller, C., Tienghi, A., Wiebe, T., Comandone, A., Böhling, T., Del Prever, A.B., Brosjö, O., Bacci, G., Saeter, G. J. Clin. Oncol. (2005) [Pubmed]
  11. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma. Ferrari, S., Bertoni, F., Zanella, L., Setola, E., Bacchini, P., Alberghini, M., Versari, M., Bacci, G. Cancer (2004) [Pubmed]
  12. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A.B., Fagioli, F., Comandone, A., Bacci, G. J. Clin. Oncol. (2003) [Pubmed]
  13. Urinary excretion of pyridinium cross-links and serum osteocalcin levels in patients with primary high-grade osteosarcoma. Ferrari, S., Zolezzi, C., Pratelli, L., Fasano, M.C., Bacci, G. Calcif. Tissue Int. (2003) [Pubmed]
  14. Somatostatin receptor (SSTR) scintigraphy in patients with osteosarcoma. Ferrari, S., Dondi, M., Fanti, S., Zoboli, S., Giacomini, S., Mercuri, M., Bacci, G. Cancer Biother. Radiopharm. (2003) [Pubmed]
  15. Ewing's sarcoma of bone: relation between clinical characteristics and staging. Ferrari, S., Bertoni, F., Mercuri, M., Sottili, S., Versari, M., Bacci, G. Oncol. Rep. (2001) [Pubmed]
  16. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ferrari, S., Bertoni, F., Mercuri, M., Picci, P., Giacomini, S., Longhi, A., Bacci, G. Ann. Oncol. (2001) [Pubmed]
  17. Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response. Ferrari, S., Mercuri, M., Picci, P., Bertoni, F., Brach del Prever, A., Tienghi, A., Mancini, A., Longhi, A., Rimondini, S., Donati, D., Manfrini, M., Ruggieri, P., Biagini, R., Bacci, G. Tumori (1999) [Pubmed]
WikiGenes - Universities